Combining Liver and Pancreatic Resections Is Safe
By HospiMedica International staff writers Posted on 15 Apr 2014 |
Combined liver and pancreatic resection (CLPR) is safe and can be performed with fairly low morbidity and mortality rates, according to a new study.
Researchers at the University of Strasbourg (France) conducted a review of two prospectively maintained databases for pancreatic and liver resections to identify patients who underwent CLPR between January 1994 and January 2012. The researchers then examined the clinical, pathological, and surgical outcomes and analyzed postoperative morbidity results. In all, 50 consecutive patients with a median age of 58 years underwent CLPR. Indications for surgery included neuroendocrine carcinoma (16 patients), biliary cancer (15), colonic cancer (5), duodenal cancer (1), and others (13).
The type of pancreatic resection included pancreaticoduodenectomy (30), distal pancreatectomy (17), spleen-preserving distal pancreatectomy (2) and total pancreatectomy (1). Twenty-three patients had associated major hepatectomies, 27 underwent minor liver resections, and 11 had associated vascular resections. The analysis showed no differences in postoperative morbidity in relation to extent of liver resection or type of pancreatic resection. The use of preoperative chemotherapy was the only independent risk factor associated with postoperative morbidity. The study was published on April 4, 2014, in the British Journal of Surgery.
“In Western countries, combined liver and pancreatic resections are performed rarely because of the perceived high morbidity and mortality rates,” said lead author Pietro Addeo, MD, of the University of Strasbourg Hôpital de Hautepierre-Hôpitaux, adding that the new study showed that “CLPR can be performed with fairly low morbidity and mortality rates. Patients receiving chemotherapy should be evaluated carefully before surgery is considered.”
Combined resection of both the liver and pancreas remains a controversial procedure. For many, the need for such an extended procedure implies a scope of disease spread that is usually not amenable to surgical control, and the extent of the procedure exposes the patients to substantial operative risks.
Related Links:
University of Strasbourg
Researchers at the University of Strasbourg (France) conducted a review of two prospectively maintained databases for pancreatic and liver resections to identify patients who underwent CLPR between January 1994 and January 2012. The researchers then examined the clinical, pathological, and surgical outcomes and analyzed postoperative morbidity results. In all, 50 consecutive patients with a median age of 58 years underwent CLPR. Indications for surgery included neuroendocrine carcinoma (16 patients), biliary cancer (15), colonic cancer (5), duodenal cancer (1), and others (13).
The type of pancreatic resection included pancreaticoduodenectomy (30), distal pancreatectomy (17), spleen-preserving distal pancreatectomy (2) and total pancreatectomy (1). Twenty-three patients had associated major hepatectomies, 27 underwent minor liver resections, and 11 had associated vascular resections. The analysis showed no differences in postoperative morbidity in relation to extent of liver resection or type of pancreatic resection. The use of preoperative chemotherapy was the only independent risk factor associated with postoperative morbidity. The study was published on April 4, 2014, in the British Journal of Surgery.
“In Western countries, combined liver and pancreatic resections are performed rarely because of the perceived high morbidity and mortality rates,” said lead author Pietro Addeo, MD, of the University of Strasbourg Hôpital de Hautepierre-Hôpitaux, adding that the new study showed that “CLPR can be performed with fairly low morbidity and mortality rates. Patients receiving chemotherapy should be evaluated carefully before surgery is considered.”
Combined resection of both the liver and pancreas remains a controversial procedure. For many, the need for such an extended procedure implies a scope of disease spread that is usually not amenable to surgical control, and the extent of the procedure exposes the patients to substantial operative risks.
Related Links:
University of Strasbourg
Latest Surgical Techniques News
- Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health
- Tiny Robots Made Out Of Carbon Could Conduct Colonoscopy, Pelvic Exam or Blood Test
- Miniaturized Ultrasonic Scalpel Enables Faster and Safer Robotic-Assisted Surgery
- AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy Detects More Lesions
- First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
- Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery